Want to join the conversation?
In 1Q17, pro forma revenues in $CSRA's Defense and Intelligence segment fell by 8% compared to 1Q16. The largest source of this reduction was the US Army Logistics Modernization Program, which continues to decline after a successful deployment phase. In the Civil segment, pro forma revenues fell by 2% from the prior year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?